David Planchard, MD, PhD

Head of Thoracic Group
Department of Medical Oncology, Institut Gustave Roussy, Thoracic Group and International Centre for Thoracic Cancers, France

Poster(s):

• (301) Zongertinib in patients with pretreated human epidermal growth factor receptor 2-mutant advanced non–small cell lung cancer: Beamion LUNG-1
  Wednesday, October 29, 2025